BioMark Diagnostics's total assets for Q3 2024 were C$876.63K, a decrease of -0.14% from the previous quarter. TSE:BUX total liabilities were C$1.97M for the fiscal quarter, a 3.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.